ADCT
ADC Therapeutics SA
Company Overview
| Mkt Cap | $498.37M | Price | $4.46 |
| Volume | 533.80K | Change | -3.67% |
| P/E Ratio | -3.2 | Open | $4.61 |
| Revenue | $70.8M | Prev Close | $4.63 |
| Net Income | $-157.8M | 52W Range | $1.05 - $4.80 |
| Div Yield | N/A | Target | $8.00 |
| Overall | 48 | Value | 40 |
| Quality | 39 | Technical | 66 |
No chart data available
Stock Overview
Updated DailyADC Therapeutics SA (ADCT) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $4.46 with a market capitalization of $498.37 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows ADCT with a volume of 534K shares. The stock opened down 0.43% from yesterday's close of $4.63. Current analyst estimates project earnings of $-1.68 per share for this year, with next year targeting $-1.67.
ADCT demonstrates positive technical signals based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for ADCT include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 79.4%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:14 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ADCT | $4.46 | -3.7% | 533.80K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |